The company seeks to identify, manage, and mitigate risks to its business, recognizing that uncertainties and risks are difficult to predict and many are outside of its control. The company has robust business continuity plans in place across its global supply chain network to help mitigate the impact of COVID-19, although these efforts may not completely prevent adverse effects on its business. The company continues to leverage its global manufacturing footprint and dual-source capabilities while closely monitoring and maintaining critical inventory to ensure adequate distribution. The company has a diversified business model across the healthcare industry with flexibility designed into its manufacturing, research and development clinical operations, and commercial capabilities. The company’s ability to absorb strain and preserve functioning despite adversity is reflected in its commitment to operational continuity and resilience strategies. The company has put procedures in place to protect its essential workforce while ensuring appropriate remote working protocols for other employees. The company’s high-quality credit rating allows superior access to financial capital markets, enhancing its resilience in times of economic uncertainty. The company continues to monitor global legislative efforts to combat the impact of COVID-19 on economies and sectors in which it participates. The company’s operations are subject to various worldwide healthcare changes that may result in pricing pressures and changes in behavior and spending patterns of purchasers of healthcare products and services. The company has established a global vaccine supply network involving multiple manufacturing sites to ensure a robust response to public health needs. The company’s strategic initiatives include expanding its use of strategic collaborations and bolstering initiatives to reduce complexity, thereby enhancing operational flexibility and agility. The company’s commitment to research and development reflects its focus on innovation and adaptability to meet evolving healthcare needs. The company’s organizational practices emphasize the importance of maintaining a diverse and skilled workforce, which is critical for fostering resilience and ensuring effective succession planning. The company’s ability to foresee and confront challenges is integral to its organizational health and performance maintenance. The company actively engages in risk assessment and management to navigate external pressures and maintain competitive advantage. The company’s focus on resource generation and allocation, as well as its strategic response to environmental disruptions, underscores its commitment to organizational resilience. The company’s approach to crisis management and preparedness is designed to ensure continuity of operations and service delivery under unexpected situations. The company recognizes the importance of stakeholder engagement and collaboration networks in enhancing its resilience capabilities. The company’s operational management strategies are aimed at optimizing resource utilization and ensuring effective response mechanisms to address complex situations and challenges. The company’s emphasis on organizational learning and knowledge management is essential for fostering innovation and adaptability in a rapidly changing business environment.